Table 2 Treatment-related adverse events
No IMP321 N (%) | IMP321 N (%) | No IMP321 N (%) | IMP321 N (%) | |
|---|---|---|---|---|
Treatment-related event | ||||
Non-hematological | Grade 1-2 | Grade 3-4 | ||
Fatigue | 6 (100%) | 6 (100%) | - | - |
Nausea/Vomiting | 5 (83%) | 1 (16.6%) | - | - |
Constipation | - | - | 1 (16.6%) | - |
Alopecia | 6 (100%) | 6 (100%) | - | - |
Mucositis (oral) | - | 1 (16.6%) | - | - |
Weight loss | 6 (100%) | 6 (100%) | - | - |
Hematological | ||||
Anemia | 4 (66.6%) | 5 (83%) | 1 (16.6%) | 1 (16.6%) |
Leucopenia | - | - | 6 (100%) | 6 (100%) |
Trombocitopenia | - | 4 (66.6%) | 4 (66.6%) | 2 (33%) |
Febrile Neutropenia (grade 3) | n/a | n/a | 2 (33%) | 3 (50%) |
CD4 Lymphopenia (≥ grade 3) | n/a | n/a | 6 (100%) | 6 (100%) |